CAN-2409 resulted in disease-free survival improvements for patients with high-risk, localized prostate cancer. Among patients with localized prostate cancer, the viral immunotherapy CAN-2409 has ...

Credit: Getty Images Large language models leverage transformed architecture to extract and summarize unstructured electronic health record data, enabling automated retrieval of clinically relevant ...

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.

Assessments used to calculate cardiovascular disease risk in the general population may not have the same predictive power ...

Development and Validation of an Adapted Tool to Measure Health-Related Social Needs for the Prostate Cancer Population in Nigeria This study included 110 patients with a median age of 67 years. Most ...

Short-term androgen deprivation combined with high-dose radiation therapy aids oncologic control in localized prostate cancer. In patients with intermediate- or high-risk localized prostate cancer, ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

Long-used imaging strategies such as computed tomography (CT) and bone scintigraphy (BS) to detect lymph node and bone metastases have significant limitations and disadvantages. Newly emerging ...